Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Savion Gropper"'
Autor:
Lesley G. Mitchell, Daniel Röshammar, Fenglei Huang, Manuela Albisetti, Leonardo R. Brandão, Lisa Bomgaars, Elizabeth Chalmers, Jacqueline Halton, Matteo Luciani, David Joseph, Igor Tartakovsky, Savion Gropper, Martina Brueckmann
Publikováno v:
Thrombosis and haemostasis. 122(9)
Background Dabigatran etexilate, a direct oral thrombin inhibitor, is approved to treat venous thromboembolism (VTE) in both adults and children. Objectives This population analysis characterized relationships between dabigatran total plasma concentr
Autor:
Martina Brueckmann, Lisa Bomgaars, Martin Bergstrand, Lesley G. Mitchell, Moustafa M. A. Ibrahim, Leonardo R. Brandão, Elizabeth Chalmers, Savion Gropper, Fenglei Huang, Jacqueline Halton, Matteo Luciani, Igor Tartakovsky, David Joseph, Manuela Albisetti, Daniel Röshammar
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Dabigatran etexilate (DE), a direct oral thrombin inhibitor, has been evaluated in children with venous thromboembolism (VTE) using oral solution, pellets, or capsules. Objectives This study evaluated DE pharmacokinetics (PK) in children w
Autor:
Marc Ferrante, Peter M Irving, Christian P Selinger, Geert D’Haens, Tanja Kuehbacher, Ursula Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus, Brian G. Feagan
Publikováno v:
Expert opinion on drug safety.
BACKGROUND: Interleukin (IL)-36 signaling has been shown to be increased in ulcerative colitis (UC). Spesolimab, a novel humanized monoclonal antibody, targets the IL-36 pathway. RESEARCH DESIGN AND METHODS: We report safety, immunogenicity, and effi
Autor:
Marla C. Dubinsky, Rory Collins, Maria T. Abreu, Vipul Jairath, James D. Lewis, James Lindsay, Miriam Merad, Siew Ng, Remo Panaccione, Julian Panes, Bruce Sands, Corey A. Siegal, Siddarth Singh, Severine Vermeire, Vineet Ahuja, Matthieu Allez, Ashwin Ananthakrishnan, Willem Bemelman, Jonathan Braun, Jean-Frederic Colombel, Silvio Danese, Geert D’Haens, André D’Hoore, Axel Dignass, Iris Dotan, Miguel Angel Gassul, Anne Griffiths, Jonas Halfvarson, Stephen Hanauer, Paulo Kotze, Ioannis Koutroubakis, Edward Loftus, Edouard Louis, Fernando Magro, Gerassimos Mantzaris, Jean-Yves Mary, Dermot McGovern, Pia Munkholm, Colm O’Morain, Yves Panis, Laurent Peyrin-Biroulet, Cosimo Prantera, Zhihua Ran, Britta Siegmund, Mark Silverberg, Eduard Stange, Stephan Targan, Curt Tysk, Simon Travis, Morton Vatn, Yesus Yamamoto-Furusho, Janske Aarts, Brihad Abhyankar, Harris Ahmad, Richard Aranda, Vipin Arora, Jalil Benjacoub, Sofie Berg, Robin Besuyen, Daniela Bojic, Valerio Carriero, Fabio Cataldi, Laurence D’Agay, Silvia Delgado-Aros, Paul Giannasca, Kavitha Goyal, Roland Greinwald, Savion Gropper, Shunsuke Kageyama, Raphaël Laoun, Barrett Levesque, Trevor Lissoos, Irene Modesto, Ralf Mohrbacher, Ralph Mueller, April Naegeli, Snehal Naik, Deanne Nguyen, Wojciech Niezychowski, Caitriona O’Brien, Irina Odnoletkova, Alessandra Oortwijn, Kun K.T. Park, Waldemar Radziszewski, Leonardo Salese, Johannes Spleiss, Andrea Stancati, Amanda Tatro, Jennifer Thompson, Robert Hofmann, Javier Zambrano, Wen Zhou, Ellen Zigmont
Publikováno v:
International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) 2021, ' Challenges and Opportunities in IBD Clinical Trial Design ', Gastroenterology, vol. 161, no. 2, pp. 400-404 . https://doi.org/10.1053/j.gastro.2021.03.065
Gastroenterology, 161(2), 400-404. W.B. Saunders Ltd
Gastroenterology, 161(2), 400-404. W.B. Saunders Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c272afd267a593087dd98af0c866112
https://curis.ku.dk/portal/da/publications/challenges-and-opportunities-in-ibd-clinical-trial-design(b6b0ec30-7f3c-4165-a128-1f4e70ec620b).html
https://curis.ku.dk/portal/da/publications/challenges-and-opportunities-in-ibd-clinical-trial-design(b6b0ec30-7f3c-4165-a128-1f4e70ec620b).html
Autor:
Jacqueline Halton, Leonardo R Brandão, Matteo Luciani, Lisa Bomgaars, Elizabeth Chalmers, Lesley G Mitchell, Ildar Nurmeev, Anjali Sharathkumar, Pavel Svirin, Kirill Gorbatikov, Igor Tartakovsky, Monika Simetzberger, Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Paul Reilly, Martina Brueckmann, Manuela Albisetti, Asiya Safina, Ondrej Zapletal, Tomas Kuhn, Tomas Votava, Judy Felgenhauer, Ali Amid, Paola Saracco, Csongor Kiss, Susan Halimeh, Madlen Reschke, Beate Wulff, Michele David, Zbynek Novak, Inna Trunina, Tony Frisk, Heidi Glosli, Andreas Groll, Olga Lvova, Ilgen Sasmaz, Darintr Sosothikul, Virginija Zilinskaite, Erin Cockrell, Valeriy Digtyar, Ivana Hadacova, Sauli Palmu, Anjali Pawar, Joyce Maria Annichino Bizzacchi, Umran Caliskan, Tiraje Celkan, Dmytro Dmytriiev, Colleen Harkins Druzgal, Graciela Onelda Elena, Antonis Kattamis, Ramazan Kaan Kavakli, Christoph Male, Nihal Ozdemir, An Van Damme, Tatiana Zvereva, Aanen Aarli, Rogelio Alejandro Paredes Aguilera, Selin Aytac, Jorge Carneiro, Antonio Chistolini, Maria Gabriela Mazzucconi, Fernando Corrales-Medina, Francis Couturaud, Stacey E Croteau, Cameron Trenor III, Michael Damgaard, Natalia Dixon, Anna Galustyan, Jiri Hak, Marianne Hoffmann, Alphan Kupesiz, Veerle Labarque, Christel van Geet, Ming-Chih Lin, Yun-Ching Fu, Sandra Loggetto, Veerle Mondelaers, Irena Odri-Komazec, Shoshana Revel-Vilk, Julian Sevilla, Luciano Fuzzato Silva, José Kerr Saraiva, Fernando Felix Montes Tapia, Wendy Woods-Swafford
Publikováno v:
The Lancet. Haematology, Vol. 8, no.1, p. e22-e33 (2021)
BACKGROUND: Dabigatran etexilate is a direct oral anticoagulant with potential to overcome the limitations of standard of care in children with venous thromboembolism. The aims of this clinical trial were to study the appropriateness of a paediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6576a5afe58bf10852f806c3c8eb49
https://hdl.handle.net/2078.1/260410
https://hdl.handle.net/2078.1/260410
Autor:
Kirill Gorbatikov, Martina Brueckmann, Monika Simetzberger, Diversity Trial Investigators, Matteo Luciani, Ildar Nurmeev, Leonardo R. Brandão, Manuela Albisetti, Pavel Svirin, Paul A. Reilly, Lisa Bomgaars, Savion Gropper, Jacqueline Halton, Fenglei Huang, Anjali Sharathkumar, Jörg Kreuzer, Elizabeth Chalmers, Lesley G. Mitchell, Zhichao Sun, Igor Tartakovsky
Publikováno v:
SSRN Electronic Journal.
Background: Dabigatran etexilate, a direct oral anticoagulant, may be an effective and safe alternative for treating acute venous thromboembolism (VTE) in children. Methods: This open-label, randomised (2:1), phase 2b/3 trial evaluated the efficacy a
Autor:
Igor Tartakovsky, Martina Brueckmann, Lesley G. Mitchell, Fenglei Huang, Hugo Maas, Joachim Stangier, Savion Gropper, Jacqueline Halton
Publikováno v:
Thrombosis and Haemostasis
Background Physiological age-related changes in the haemostatic and coagulation systems result in differing anticoagulant assay responses to standard anticoagulants. Therefore, we investigated the response of anticoagulant assays to dabigatran etexil
Autor:
Elizabeth Chalmers, Manuela Albisetti, Martina Brueckmann, Lisa Bomgaars, Savion Gropper, Jacqueline Halton, Igor Tartakovsky, Bushi Wang, Ruth Harper, Lesley G. Mitchell, Matteo Luciani, Fenglei Huang, Ivan Manastirski, Leonardo R. Brandão, Branislav Biss
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Background Anticoagulant therapy for venous thromboembolism (VTE) in children is largely based on treatment recommendations for adults. However, differences in both physiology (ie, renal maturation and drug excretion) and developmental hemostasis mus
Autor:
Igor Tartakovsky, Manuela Albisetti, Martina Brueckmann, Lesley G. Mitchell, Ivan Manastirski, Lisa Bomgaars, Savion Gropper, Matteo Luciani, Jacqueline Halton, Branislav Biss, Fenglei Huang, Bushi Wang, Elizabeth Chalmers, Leonardo R. Brandão, Ruth Harper
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Essentials Current standard of care (SOC) for pediatric venous thromboembolism (VTE) has limitations.Dabigatran etexilate (DE) versus SOC will be studied in children with VTE in a phase IIb/III trial.A dosing algorithm for DE in children will be asse
Autor:
Lisa Bomgaars, Lesley G. Mitchell, Igor Tartakovsky, Matteo Luciani, Savion Gropper, Jacqueline Halton, Ruth Harper, Manuela Albisetti, Hugo Maas, Fenglei Huang, Branislav Biss, Martina Brueckmann
Publikováno v:
Journal of Thrombosis and Haemostasis. 15:2147-2157
Essentials Dabigatran etexilate may provide a new treatment option for pediatric venous thromboembolism. Children aged 1 to < 12 years were given dabigatran etexilate in an open-label, single-arm study. The pharmacokinetic–pharmacodynamic relations